Style | Citing Format |
---|---|
MLA | Jadidi N, et al.. "Mirna-Binding Site Polymorphism In Il-15Ra Gene in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation With Disease Risk and Clinical Characteristics." Clinical Rheumatology, vol. 41, no. 11, 2022, pp. 3487-3494. |
APA | Jadidi N, Alesaeidi S, Arab F, Pakzad B, Siasi E, Esmaeilzadeh E (2022). Mirna-Binding Site Polymorphism In Il-15Ra Gene in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation With Disease Risk and Clinical Characteristics. Clinical Rheumatology, 41(11), 3487-3494. |
Chicago | Jadidi N, Alesaeidi S, Arab F, Pakzad B, Siasi E, Esmaeilzadeh E. "Mirna-Binding Site Polymorphism In Il-15Ra Gene in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation With Disease Risk and Clinical Characteristics." Clinical Rheumatology 41, no. 11 (2022): 3487-3494. |
Harvard | Jadidi N et al. (2022) 'Mirna-Binding Site Polymorphism In Il-15Ra Gene in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation With Disease Risk and Clinical Characteristics', Clinical Rheumatology, 41(11), pp. 3487-3494. |
Vancouver | Jadidi N, Alesaeidi S, Arab F, Pakzad B, Siasi E, Esmaeilzadeh E. Mirna-Binding Site Polymorphism In Il-15Ra Gene in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation With Disease Risk and Clinical Characteristics. Clinical Rheumatology. 2022;41(11):3487-3494. |
BibTex | @article{ author = {Jadidi N and Alesaeidi S and Arab F and Pakzad B and Siasi E and Esmaeilzadeh E}, title = {Mirna-Binding Site Polymorphism In Il-15Ra Gene in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation With Disease Risk and Clinical Characteristics}, journal = {Clinical Rheumatology}, volume = {41}, number = {11}, pages = {3487-3494}, year = {2022} } |
RIS | TY - JOUR AU - Jadidi N AU - Alesaeidi S AU - Arab F AU - Pakzad B AU - Siasi E AU - Esmaeilzadeh E TI - Mirna-Binding Site Polymorphism In Il-15Ra Gene in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation With Disease Risk and Clinical Characteristics JO - Clinical Rheumatology VL - 41 IS - 11 SP - 3487 EP - 3494 PY - 2022 ER - |